Evidence map›Paper›PMID 37373636›Full record

ArticleJournal of clinical medicine2023

Diagnostic Performance of Dynamic Whole-Body Patlak [

Matthias Weissinger, Max Atmanspacher, Werner Spengler, Ferdinand Seith, Sebastian Von Beschwitz, Helmut Dittmann, Lars Zender, Anne M Smith, Michael E Casey, Konstantin Nikolaou and 2 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Exploring extended [European journal of nuclear medicine and molecular imaging · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Matthias WeissingerDepartment of Nuclear Medicine and Clinical Molecular Imaging, University Hospital Tuebingen, 72076 Tuebingen, Germany.ORCID 0000-0003-2044-3047
Max AtmanspacherDepartment of Nuclear Medicine and Clinical Molecular Imaging, University Hospital Tuebingen, 72076 Tuebingen, Germany.
Werner SpenglerDepartment for Internal Medicine VIII, University Hospital Tuebingen, 72076 Tuebingen, Germany.ORCID 0009-0003-0522-1531
Ferdinand SeithDepartment of Diagnostic and Interventional Radiology, University Hospital Tuebingen, 72076 Tuebingen, Germany.ORCID 0000-0002-9696-2954
Sebastian Von BeschwitzDepartment of Nuclear Medicine and Clinical Molecular Imaging, University Hospital Tuebingen, 72076 Tuebingen, Germany.
Helmut DittmannDepartment of Nuclear Medicine and Clinical Molecular Imaging, University Hospital Tuebingen, 72076 Tuebingen, Germany.ORCID 0000-0001-6840-5571
Lars ZenderDepartment for Internal Medicine VIII, University Hospital Tuebingen, 72076 Tuebingen, Germany.
Anne M SmithSiemens Medical Solutions USA, Inc., Molecular Imaging, Knoxville, TN 37932, USA.
Michael E CaseySiemens Medical Solutions USA, Inc., Molecular Imaging, Knoxville, TN 37932, USA.
Konstantin NikolaouDepartment of Diagnostic and Interventional Radiology, University Hospital Tuebingen, 72076 Tuebingen, Germany.ORCID 0000-0003-2668-7325
Salvador Castaneda-VegaDepartment of Nuclear Medicine and Clinical Molecular Imaging, University Hospital Tuebingen, 72076 Tuebingen, Germany.ORCID 0000-0002-0484-9904
Christian la FougèreDepartment of Nuclear Medicine and Clinical Molecular Imaging, University Hospital Tuebingen, 72076 Tuebingen, Germany.
Deutschen Konsortium für Translationale Krebsforschung · DESiemens (Germany) · DE

Funding

Deutsche Forschungsgemeinschaft EXC 2180 - 390900677
6 · The paper itself

Abstract

backgroundStatic [

methodsA total of 34 consecutive patients with indeterminate pulmonary lesions were enrolled in this prospective trial. All patients underwent static (60 min p.i.) and dynamic (0-60 min p.i.) whole-body [

resultsMR-FDG

conclusionsMetabolic rate quantification was shown to be a reliable method to detect malignant lung tumors, LNM, and distant metastases at least as accurately as the established SUV or dual-time-point PET scans.

Indexed as

dynamic PETFDGparametric FDGPatlakPET/CTwhole-body

Identifiers

PMID37373636
PMCPMC10299392
OpenAlexW4380083219

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.